Twist Bioscience (TWST) Soars 12.5%: Is Further Upside Left in the Stock?Zacks Investment Research • 12/15/23
DNA-Maker Twist Bioscience Catapults 21% As 'Solid' Outlook That Tops Its PeersInvestors Business Daily • 11/17/23
Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2023 Financial ResultsBusiness Wire • 11/17/23
Twist Bioscience to Report Fiscal 2023 Fourth Quarter and Full Year Financial Results on Friday, November 17, 2023Business Wire • 11/02/23
Twist Bioscience Launches Full Length Unique Dual Index Adapters to Enable PCR-free Whole Genome SequencingBusiness Wire • 10/31/23
Twist Bioscience Enters into Antibody Discovery and Licensing Option Agreement with Bayer of up to $188 MillionBusiness Wire • 10/05/23
Twist Bioscience and IMIDomics Collaborate to Discover Antibodies for Applications in Immune-Mediated Inflammatory DiseasesBusiness Wire • 09/27/23
Twist Bioscience Enters into Agreement with Ono Pharmaceutical to Discover Novel Antibodies for Autoimmune DiseasesBusiness Wire • 08/31/23
Twist Bioscience Releases 2023 ESG Report and Quantifies Carbon Footprint of Manufacturing a Single GeneBusiness Wire • 08/22/23
Twist Bioscience to Present at the UBS MedTech, Tools and Genomics Summit 2023Business Wire • 08/07/23